Terril Brothers’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-25,685
Closed -$2.55M 59
2019
Q3
$2.55M Sell
25,685
-110
-0.4% -$10.5K 0.86% 22
2019
Q2
$2.38M Sell
25,795
-13,925
-35% -$1.32M 0.76% 24
2019
Q1
$3.75M Sell
39,720
-3,600
-8% -$315K 1.18% 21
2018
Q4
$2.78M Sell
43,320
-1,655
-4% -$122K 1% 22
2018
Q3
$4.03M Buy
44,975
+3,330
+8% +$294K 1.24% 21
2018
Q2
$3.31M Buy
41,645
+12,350
+42% +$1.03M 1.02% 24
2018
Q1
$2.61M Buy
+29,295
New +$2.81M 0.79% 24

Other funds holding CELG

Terril Brothers's CELG Position: Q4 2019 in Review

Terril Brothers sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 25,685 shares — an estimated $2.55M sold.

Terril Brothers first reported a position in CELG in Q1 2018 and held it in 7 quarters. The position peaked at $4.03M in Q3 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Terril Brothers reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Terril Brothers sold 25,685 Celgene Corp shares in Q4 2019, an estimated $2.55M.
  • Terril Brothers first reported a position in Celgene Corp in Q1 2018 and held it in 7 quarters.
  • Terril Brothers's Celgene Corp position peaked at $4.03M in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Terril Brothers's 13F filing for Q4 2019, filed 5 Feb 2020.